Can MMRV (Measles, Mumps, Rubella, and Varicella) and Hep B (Hepatitis B) vaccines be administered together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MMRV and Hepatitis B Vaccines Can Be Safely Administered Together

Yes, MMRV and Hepatitis B vaccines can and should be administered simultaneously at the same visit. The CDC explicitly recommends that varicella, MMR, and hepatitis B vaccines can be safely given together, producing comparable seroconversion rates and adverse reaction profiles to separate administration 1.

Evidence Supporting Simultaneous Administration

Guideline Recommendations

  • The ACIP guidelines confirm that simultaneous administration of MMR, hepatitis B vaccine, and other routine childhood vaccines does not impair antibody responses or increase adverse reaction rates 2.
  • Hepatitis B vaccine administered with other vaccines is as safe and immunogenic as when given separately, with no compromise on immunogenicity or safety 1.
  • Inactivated vaccines like hepatitis B can be administered at any time before or after a different inactivated or live vaccine, with no restrictions on co-administration 1.

Clinical Trial Data

  • A large clinical trial involving 1,913 healthy children aged 12-15 months demonstrated that concomitantly administered MMRV vaccine, DTaP, Hib conjugate vaccine, and hepatitis B vaccine showed comparable seroconversion rates and antibody titers for all vaccine components 1.
  • In a study of 822 children aged 12-15 months, concomitant administration of Hib-hepatitis B vaccine with MMR and varicella vaccines resulted in satisfactory antibody responses: hepatitis B surface antigen (99.2-100%), measles (99.4-99.6%), mumps (98.4-99.2%), rubella (100%), and varicella (93.2-94.6%) 3.
  • Another study of 197 adolescents confirmed that concomitant hepatitis B, Td, and MMR vaccination showed no significant difference in rates of protective immunity compared to nonconcomitant vaccination 4.

Practical Implementation

Administration Guidelines

  • All vaccines should be administered at separate anatomical sites using separate syringes 2, 1.
  • The standard dose volume of 0.5 mL should be used for each vaccine 2.
  • Simultaneous administration is particularly important when healthcare providers anticipate that a child might not return for subsequent vaccination 1.

Timing Considerations

  • If vaccines are not administered simultaneously, live vaccines (MMR and varicella components of MMRV) should be given at least 28 days apart 2, 1.
  • However, hepatitis B as an inactivated vaccine has no timing restrictions and can be given at any interval before or after live vaccines 1.

Safety Profile

Expected Adverse Events

  • The safety profiles for concomitant administration are comparable to separate administration 5, 3.
  • Most adverse events are mild and transient, including injection-site pain, redness, fatigue, and headache 6.
  • In the large pediatric study, serious adverse events were rare (15 total events in 1,915 children), with only two possibly related to vaccination 5.

Important Precautions

  • Check for contraindications before administering multiple vaccines, including severe allergic reactions to vaccine components, immunodeficiency, or moderate to severe acute illness 2.
  • For HIV-infected children, special considerations apply: MMR and varicella vaccines may be given if CD4+ T-lymphocyte count is >15% 2.

Clinical Benefits

Improved Vaccination Coverage

  • Simultaneous administration reduces the number of injections children receive and increases the probability of full immunization at the appropriate age 1, 7.
  • Combination vaccines and simultaneous administration have been associated with 3-6% increased coverage for component vaccines 2.
  • Multiple studies indicate parent and provider preference for fewer injections at one visit 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.